Response to: 'Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al
- PMID: 31208959
- PMCID: PMC8466717
- DOI: 10.1136/annrheumdis-2019-215693
Response to: 'Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh S et al' by Yang et al
Keywords: autoantibodies; dermatomyositis; polymyositis.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.Ann Rheum Dis. 2019 Jul;78(7):988-995. doi: 10.1136/annrheumdis-2018-215004. Epub 2019 Apr 24. Ann Rheum Dis. 2019. PMID: 31018961 Free PMC article.
-
Comment on: 'Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis' by Sabbagh et al.Ann Rheum Dis. 2020 Aug;79(8):e96. doi: 10.1136/annrheumdis-2019-215678. Epub 2019 May 16. Ann Rheum Dis. 2020. PMID: 31097420 No abstract available.
References
-
- Yang Z and Liang Y. Response to : ‘anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al. Ann Rheum Dis. 2019. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
